BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oka S, Kanagawa M, Doi Y, Schuster DM, Goodman MM, Yoshimura H. PET Tracer 18F-Fluciclovine Can Detect Histologically Proven Bone Metastatic Lesions: A Preclinical Study in Rat Osteolytic and Osteoblastic Bone Metastasis Models. Theranostics 2017;7:2048-64. [PMID: 28656060 DOI: 10.7150/thno.19883] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Husseini JS, Balza R, Evangelista L, Cañamaque LG, Catalano OA. PET/MR for evaluation of musculoskeletal malignancies. Clin Transl Imaging. [DOI: 10.1007/s40336-021-00470-9] [Reference Citation Analysis]
2 Romagnolo C, Cottignoli C, Palucci A, Biscontini G, Fringuelli FM, Burroni L. Pictorial essay: incidental findings on 18F-Fluciclovine PET/CT scan. Clin Transl Imaging 2021;9:189-98. [DOI: 10.1007/s40336-021-00412-5] [Reference Citation Analysis]
3 Kim EH, Siegel BA, Teoh EJ, Andriole GL; LOCATE Study Group. Prostate cancer recurrence in patients with negative or equivocal conventional imaging: A role for 18F-fluciclovine-PET/CT in delineating sites of recurrence and identifying patients with oligometastatic disease. Urol Oncol 2021;39:365.e9-365.e16. [PMID: 33160848 DOI: 10.1016/j.urolonc.2020.10.017] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Cook GJR, Goh V. Molecular Imaging of Bone Metastases and Their Response to Therapy. J Nucl Med 2020;61:799-806. [PMID: 32245899 DOI: 10.2967/jnumed.119.234260] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Robertson MS, Sakellis CG, Hyun H, Jacene HA. Extraprostatic Uptake of 18F-Fluciclovine: Differentiation of Nonprostatic Neoplasms From Metastatic Prostate Cancer. AJR Am J Roentgenol 2020;214:641-8. [PMID: 31939697 DOI: 10.2214/AJR.19.21894] [Cited by in Crossref: 8] [Article Influence: 4.0] [Reference Citation Analysis]
6 Nanni C, Zanoni L, Bach-gansmo T, Minn H, Willoch F, Bogsrud TV, Edward EP, Savir-baruch B, Teoh E, Ingram F, Fanti S, Schuster DM. [18F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging—version 1.0. Eur J Nucl Med Mol Imaging 2020;47:579-91. [DOI: 10.1007/s00259-019-04614-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
7 Morodomi Y, Kanaji S, Won E, Kawamoto T, Kanaji T. Modified application of Kawamoto's film method for super-resolution imaging of megakaryocytes in undecalcified bone marrow. Res Pract Thromb Haemost 2020;4:86-91. [PMID: 31989088 DOI: 10.1002/rth2.12276] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
8 Cook GJR. Performance of 18F-fluciclovine PET/MR in the evaluation of osseous metastases from castration-resistant prostate cancer. Eur J Nucl Med Mol Imaging 2020;47:16-7. [PMID: 31624865 DOI: 10.1007/s00259-019-04540-z] [Reference Citation Analysis]
9 Amorim BJ, Prabhu V, Marco SS, Gervais D, Palmer WE, Heidari P, Vangel M, Saylor PJ, Catalano OA. Performance of 18F-fluciclovine PET/MR in the evaluation of osseous metastases from castration-resistant prostate cancer. Eur J Nucl Med Mol Imaging 2020;47:105-14. [DOI: 10.1007/s00259-019-04506-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
10 Karamzade-Ziarati N, Manafi-Farid R, Ataeinia B, Langsteger W, Pirich C, Mottaghy FM, Beheshti M. Molecular imaging of bone metastases using tumor-targeted tracers. Q J Nucl Med Mol Imaging 2019;63:136-49. [PMID: 31315347 DOI: 10.23736/S1824-4785.19.03206-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
11 Broski SM, Young JR, Kendi AT, Subramaniam RM. Skeletal Metastasis Evaluation. PET Clinics 2019;14:103-20. [DOI: 10.1016/j.cpet.2018.08.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
12 Ulaner GA, Schuster DM. Amino Acid Metabolism as a Target for Breast Cancer Imaging. PET Clin 2018;13:437-44. [PMID: 30100081 DOI: 10.1016/j.cpet.2018.02.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
13 Chau A, Gardiner P, Colletti PM, Jadvar H. Diagnostic Performance of 18F-Fluciclovine in Detection of Prostate Cancer Bone Metastases. Clin Nucl Med 2018;43:e226-31. [PMID: 29762238 DOI: 10.1097/RLU.0000000000002130] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
14 Parent EE, Schuster DM. Update on 18F-Fluciclovine PET for Prostate Cancer Imaging. J Nucl Med 2018;59:733-9. [PMID: 29523631 DOI: 10.2967/jnumed.117.204032] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 14.8] [Reference Citation Analysis]
15 Zanoni L, Bossert I, Matti A, Schiavina R, Pultrone C, Fanti S, Nanni C. A review discussing fluciclovine (18F) PET/CT imaging in the detection of recurrent prostate cancer. Future Oncol 2018;14:1101-15. [PMID: 29359581 DOI: 10.2217/fon-2017-0446] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
16 Lindenberg L. In Molecular Pursuit of Bone Metastasis by Fluciclovine PET. Theranostics 2017;7:2065-6. [PMID: 28638486 DOI: 10.7150/thno.20622] [Reference Citation Analysis]